Speaker illustration

Professor Andrew Ryabikov

Novosibirsk State Medical University, Novosibirsk (Russian Federation)

Member of:

The frequency and profile of lipid lowering treatment in a contemporary Russian population

Event: ESC Congress 2021 - The Digital Experience

Topic: Drug therapy

Session: Risk Factors and Prevention ePosters

Thumbnail

Relationship between endothelium-dependent vasodilation, carotid intima-media thickness and atherosclerotic plaques: is it preserved in the elderly?

Event: ESC Congress 2021 - The Digital Experience

Topic: Cardiovascular Disease in the Elderly

Session: Cardiovascular Disease in Special Populations ePosters

Thumbnail

The association between epigenetic age and progression of subclinical atherosclerosis in ageing cohort

Event: EuroPrevent 2019

Topic: Cardiac Diseases

Session: Moderated Posters Session 4

Thumbnail

Association between left ventricle longitudinal strain and strain rate and cardiometabolic diseases in a general population sample

Event: EuroPrevent 2019

Topic: Cross-Modality and Multi-Modality Imaging Topics

Session: Cross-Modality and Multi-Modality Imaging Topics

Thumbnail

Relationship between longitudinal strain of left ventricle and hypertension and blood pressure control in a general population

Event: EuroPrevent 2018

Topic: Cross-Modality and Multi-Modality Imaging Topics, Other

Session: Imaging

Thumbnail

Leukocyte telomere length and carotid atherosclerosis: follow-up study in ageing cohort

Event: EuroPrevent 2017

Topic: Genetics

Session: Epidemiology/ Public health_Part 2

Thumbnail

Considering fatty liver disease as a novel risk factor for cardiovascular outcomes and mortality (cohort study)

Event: EuroPrevent 2017

Topic: Epidemiology, lipids

Session: Moderated Poster Session II - Epidemiology

Thumbnail

Fatty liver disease and 20-year risk of cardiovascular outcomes and mortality

Event: ESC Congress 2016

Topic: Primary cardiovascular prevention: interventions and outcomes

Session: Predicting outcomes in cardiac vascular disease

Thumbnail

ESC 365 is supported by

logo Novo Nordisk
logo Bristol Myers Squibb